Top news of the week: 05.01.2021.
Healthcare
The Biotech Paradox of 2020: A Year In Review
2020 was an incredibly paradoxical year for those of us in biotech: the striking dichotomy of simultaneously experiencing agonizing tragedy alongside buoyant optimism. It was truly a ...
New and Emerging Drug Classes That Will Outlast the Pandemic
From synthetic polymer-based anti-infectives to antiviral conjugates and DNA vaccines, the past year has given new and emerging drug classes an opportunity to shine.
India's Vaccine Wait Over; Serum Institute, Bharat Biotech Get Approval
Two vaccines for coronavirus, Oxford Institute's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the ...
California Biotech Advances Two COVID-19 Products Research Report
Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report.
AstraZeneca and Oxford’s Bumpy Partnership Hangs Over Covid Vaccine’s Future
The latest Covid-19 vaccine won authorization in the U.K. but continues to face challenges sown by confusing trial results.
How Smart Medicine And Biotech Are Impacting Employer Health Plans In The Digital Age
With the advent of biotech and “smart health” plans, however, employer health plans are going further when it comes to incentivizing employee health.
SEC recommends Bharat Biotech’s Covaxin for emergency use
The Drug Controller General of India (DCGI) will give the final approval to both the vaccine candidates.
Covaxin can work against mutated coronavirus: Bharat Biotech
He also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with the Indian Council of Medical ...